Tag: Coronavirus

  • Update on Covid-19 vaccine

    More than four months into the coronavirus pandemic, how close are the U.S. and the world to a safe and effective vaccine? Scientists say they see steady progress and are expressing cautious optimism that a vaccine could be ready by spring. As of early July, roughly 160 vaccine projects were underway worldwide, according to the…

  • Remdesivir Liver Toxicity – case study

    Remdesivir, the only drug cleared to treat Covid-19, sped the recovery time of patients with the disease, but its benefit appeared much more limited in patients who needed mechanical ventilation as part of their treatment. Although the antiviral agent remdesivir has been shown to shorten recovery time in patients with COVID-19, it has also been…

  • Things you need to know about Favipiravir (Glenmark’s approved medicine for mild to moderate COVID-19 in India)

    Things you need to know about Favipiravir (Glenmark’s approved medicine for mild to moderate COVID-19 in India)

    Glenmark’s Fabiflu is the first oral Favipiravir-approved medication for the treatment of COVID-19 and has been launched in few centers. The Drug Controller General of India approved the anti-viral for ‘restricted emergency use’ for treatment of mild to moderate cases, which accounts for a majority of COVID-19 infections. DCGI’s approval was based on Glenmark’s phase…

  • Roche’s Elecsys IL-6 test receives FDA Emergency Use Authorisation to help in identifying patients at high risk of severe inflammatory response

    Roche’s Elecsys IL-6 test receives FDA Emergency Use Authorisation to help in identifying patients at high risk of severe inflammatory response

    On Thursday, Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for the Elecsys® IL-6 test. This test measures levels of the biomarker interleukin 6 (IL-6) and can be used to help identify patients with confirmed COVID-19 disease who could be at high risk of intubation with…

  • Solidarity trial – update from WHO

    Solidarity trial – update from WHO

    Solidarity is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners. The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs…

error: Content is protected !!